Bioventus Inc. is a medical device company. The Companyâs portfolio of products is grouped into three areas. Its Pain Treatments include the Knee Osteoarthritis (KOA) area, and Peripheral Nerve Stimulation (PNS) area. Its Surgical Solutions include Ultrasonics, which offers precision bone resection for patients with degenerative spine conditions and spinal deformities, and Bone Graft Substitutes (BGS), which includes a range of products that facilitate optimal bone fusion following a surgical procedure. Its Restorative Therapies comprise Fracture Care that provide low-intensity pulse ultrasound to help patients who suffer from bone fractures that do not heal through traditional methods. It offers a diverse portfolio of products to support physicians in relieving pain and addressing musculoskeletal challenges across indications and clinical areas, including knee, hand and upper extremities, foot and ankle, podiatry, trauma, general surgery, spine and neurosurgery.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļBVS
āļāļ·āđāļāļāļĢāļīāļĐāļąāļBioventus Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļFeb 11, 2021
āļāļĩāļāļĩāđāļClaypoole (Robert E)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ930
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļFeb 11
āļāļĩāđāļāļĒāļđāđ4721 Emperor Boulevard, Suite 100
āđāļĄāļ·āļāļDURHAM
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ27703
āđāļāļĢāļĻāļąāļāļāđ19194746700
āđāļ§āđāļāđāļāļāđhttps://www.bioventus.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļBVS
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļFeb 11, 2021
āļāļĩāļāļĩāđāļClaypoole (Robert E)
Mr. Anthony D'adamio, J.D.
Mr. Anthony D'adamio, J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
Ms. Susan M. Stalnecker
Independent Director
Mr. Guy Paul Nohra
Independent Director
Mr. Guido J. Neels
Independent Director
Mr. John A. Bartholdson
Independent Director
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
Independent Director
Ms. Michelle Mcmurry-Heath, M.D., Ph.D.
Ms. Michelle Mcmurry-Heath, M.D., Ph.D.
Independent Director
Mr. Philip G. Cowdy
Independent Director
Mr. Mark Singleton
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
Ms. Katrina Church, J.D.
Senior Vice President, Chief Compliance Officer
Senior Vice President, Chief Compliance Officer
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Anthony D'adamio, J.D.
Mr. Anthony D'adamio, J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
Ms. Susan M. Stalnecker
Independent Director
Mr. Guy Paul Nohra
Independent Director
Mr. Guido J. Neels
Independent Director
Mr. John A. Bartholdson
Independent Director
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
Independent Director
Vanguard US Multifactor ETF
VictoryShares Small Cap Free Cash Flow ETF
Harbor Human Capital Factor US Small Cap ETF
Fidelity Enhanced Small Cap ETF
Principal U.S. Small-Cap ETF
Vanguard US Value Factor ETF
WisdomTree US SmallCap Fund
Avantis US Small Cap Value ETF
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Vanguard US Multifactor ETF
āļŠāļąāļāļŠāđāļ§āļ0.1%
VictoryShares Small Cap Free Cash Flow ETF
āļŠāļąāļāļŠāđāļ§āļ0.1%
Harbor Human Capital Factor US Small Cap ETF
āļŠāļąāļāļŠāđāļ§āļ0.09%
Fidelity Enhanced Small Cap ETF
āļŠāļąāļāļŠāđāļ§āļ0.09%
iShares Micro-Cap ETF
āļŠāļąāļāļŠāđāļ§āļ0.06%
Principal U.S. Small-Cap ETF
āļŠāļąāļāļŠāđāļ§āļ0.05%
Vanguard US Value Factor ETF
āļŠāļąāļāļŠāđāļ§āļ0.04%
Humankind US Stock ETF
āļŠāļąāļāļŠāđāļ§āļ0.03%
WisdomTree US SmallCap Fund
āļŠāļąāļāļŠāđāļ§āļ0.03%
Avantis US Small Cap Value ETF
āļŠāļąāļāļŠāđāļ§āļ0.03%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
0.00
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē

āđāļĄāđāļĄāļĩāļāđāļāļĄāļđāļĨ